(SCHG) Schwab U.S. Large-Cap - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US8085243009
SCHG: ETF, Shares
The Schwab U.S. Large-Cap Growth ETF (SCHG) is designed to track the Dow Jones U.S. Large-Cap Growth Total Stock Market Index, which comprises large-cap growth stocks available in the market. This index is a subset of the Dow Jones U.S. Total Stock Market Index, focusing on the top 750 stocks by market capitalization that exhibit growth characteristics based on various factors.
The funds investment strategy is to replicate the performance of the underlying index by investing in the constituent stocks. As a result, SCHG provides investors with exposure to a diversified portfolio of large-cap growth companies in the U.S. market. The ETF is suitable for investors seeking to capitalize on the growth potential of the U.S. large-cap segment.
Analyzing the technical data, we observe that SCHG has recently broken above its 20-day Simple Moving Average (SMA) of $27.07, indicating a potential bullish trend. The 50-day SMA at $25.64 and the 200-day SMA at $26.62 suggest that the ETF has been in an overall uptrend. The Average True Range (ATR) of 1.86% indicates moderate volatility. Given the current price of $27.74, we can expect the ETF to continue its upward momentum, potentially targeting the 52-week high of $29.07.
From a fundamental perspective, SCHGs Assets Under Management (AUM) stand at $40.286 billion, indicating a significant investor presence. The ETFs large size and liquidity make it an attractive option for investors. Combining this with the technical analysis, we forecast that SCHG will continue to rise, driven by the growth momentum of its underlying constituents. If the trend persists, SCHG may reach new highs, potentially surpassing its current 52-week high.
Based on the analysis, our forecast is that SCHG will continue its upward trend, potentially reaching $30.50 within the next 6-12 months, driven by the strong growth momentum of its underlying constituents and the overall bullish market sentiment. However, investors should be cautious of potential volatility and adjust their strategies accordingly.
Additional Sources for SCHG ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
SCHG ETF Overview
Market Cap in USD | 42,185m |
Category | Large Growth |
TER | 0.04% |
IPO / Inception | 2009-12-11 |
SCHG ETF Ratings
Growth Rating | 69.2 |
Fundamental | - |
Dividend Rating | 44.9 |
Rel. Strength | 1.06 |
Analysts | - |
Fair Price Momentum | 26.95 USD |
Fair Price DCF | - |
SCHG Dividends
Dividend Yield 12m | 0.42% |
Yield on Cost 5y | 0.94% |
Annual Growth 5y | 5.54% |
Payout Consistency | 90.8% |
Payout Ratio | % |
SCHG Growth Ratios
Growth Correlation 3m | 76.9% |
Growth Correlation 12m | 35.6% |
Growth Correlation 5y | 75.9% |
CAGR 5y | 18.20% |
CAGR/Max DD 5y | 0.53 |
Sharpe Ratio 12m | 1.26 |
Alpha | -1.30 |
Beta | 1.244 |
Volatility | 15.12% |
Current Volume | 11796.8k |
Average Volume 20d | 8606.4k |
As of June 16, 2025, the stock is trading at USD 27.89 with a total of 11,796,787 shares traded.
Over the past week, the price has changed by -0.85%, over one month by +1.34%, over three months by +8.84% and over the past year by +10.46%.
Yes. Based on ValueRay´s Analyses, Schwab U.S. Large-Cap (NYSE ARCA:SCHG) is currently (June 2025) a good stock to buy. It has a ValueRay Growth Rating of 69.24 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SCHG is around 26.95 USD . This means that SCHG is currently overvalued and has a potential downside of -3.37%.
Schwab U.S. Large-Cap has no consensus analysts rating.
According to our own proprietary Forecast Model, SCHG Schwab U.S. Large-Cap will be worth about 31.3 in June 2026. The stock is currently trading at 27.89. This means that the stock has a potential upside of +12.19%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 31.3 | 12.2% |